Mouse model of X–linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production

[1]  A. Dutra,et al.  Comparative mapping of canine and human proximal Xq and genetic analysis of canine X-linked severe combined immunodeficiency. , 1994, Genomics.

[2]  S. Chanock,et al.  Gene targeting of X chromosome-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91phox. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  B. Zwilling,et al.  Macrophage-Pathogen Interactions , 1993 .

[4]  M. Gimbrone,et al.  Biological Oxidants: Generation and Injurious Consequences , 1992 .

[5]  R. Gilbert,et al.  Identification and prevalence of a genetic defect that causes leukocyte adhesion deficiency in Holstein cattle. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  John I. Gallin,et al.  Inflammation: Basic Principles and Clinical Correlates , 1992 .

[7]  M. Capecchi,et al.  Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus , 1992, Molecular and cellular biology.

[8]  A. Segal,et al.  Cytochrome b-245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes. , 1992, The Biochemical journal.

[9]  D. Rotrosen,et al.  Cytochrome b558: the flavin-binding component of the phagocyte NADPH oxidase. , 1992, Science.

[10]  D. Roos,et al.  Chronic granulomatous disease with partial deficiency of cytochrome b 558 and incomplete respiratory burst: variants of the X‐linked, cytochrome b 558–negative form of the disease , 1992, Journal of leukocyte biology.

[11]  S. Orkin,et al.  Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Rudnicki,et al.  The mouse Pgk-1 gene promoter contains an upstream activator sequence. , 1991, Nucleic acids research.

[13]  A. Segal,et al.  Killing of pathogens associated with chronic granulomatous disease by the non-oxidative microbicidal mechanisms of human neutrophils. , 1991, Journal of medical microbiology.

[14]  E. Pick,et al.  The membrane-associated component of the amphiphile-activated, cytosol-dependent superoxide-forming NADPH oxidase of macrophages is identical to cytochrome b559. , 1991, The Journal of biological chemistry.

[15]  S. Orkin,et al.  Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1 , 1991, Nature.

[16]  S. Orkin,et al.  Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. , 1990, The Journal of clinical investigation.

[17]  S. Orkin,et al.  Absence of both the 91kD and 22kD subunits of human neutrophil cytochrome b in two genetic forms of chronic granulomatous disease. , 1989, Blood.

[18]  T. Walsh,et al.  Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice , 1989, Infection and immunity.

[19]  M. Walport,et al.  Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. , 1989, The Journal of clinical investigation.

[20]  J. Jackson,et al.  Leukocyte-induced tissue injury. , 1988, Hematology/oncology clinics of North America.

[21]  J I Gallin,et al.  Current concepts: immunology. Neutrophils in human diseases. , 1987, The New England journal of medicine.

[22]  A. Jesaitis,et al.  Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. , 1987, The Journal of clinical investigation.

[23]  A. Segal.  Absence of both cytochrome b−245 subunits from neutrophils in X-linked chronic granulomatous disease , 1987, Nature.

[24]  A. Monaco,et al.  Cloning the gene for an inherited human disorder—chronic granulomatous disease—on the basis of its chromosomal location , 1986, Nature.

[25]  J. Graybill,et al.  Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191. , 1984, The American review of respiratory disease.

[26]  B. Seligmann,et al.  Recent Advances in Chronic Granulomatous Disease , 1983 .

[27]  A. Schaffner,et al.  Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. , 1982, The Journal of clinical investigation.

[28]  A. Segal,et al.  ABSENCE OF A NEWLY DESCRIBED CYTOCHROME b FROM NEUTROPHILS OF PATIENTS WITH CHRONIC GRANULOMATOUS DISEASE , 1978, The Lancet.

[29]  R. Krzesicki,et al.  Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis. , 1978, The American journal of pathology.

[30]  H. Ochs,et al.  The NBT slide test: a simple screening method for detecting chronic granulomatous disease and female carriers. , 1973, The Journal of pediatrics.

[31]  D. Nathan,et al.  Quantitative nitroblue tetrazolium test in chronic granulomatous disease. , 1968, The New England journal of medicine.

[32]  D. Williams,et al.  Effects of recombinant human interleukin-11 on hematopoietic reconstitution in transplant mice: acceleration of recovery of peripheral blood neutrophils and platelets. , 1993, Blood.

[33]  Dinauer Mc.  The respiratory burst oxidase and the molecular genetics of chronic granulomatous disease. , 1993, Critical reviews in clinical laboratory sciences.

[34]  C. Nathan,et al.  CHAPTER 9 – Macrophage-Derived Nitric Oxide: Generation and Consequences , 1992 .

[35]  W. Nauseef,et al.  Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558. , 1991, The Journal of clinical investigation.

[36]  J. Curnutte,et al.  Kinetic microplate assay for superoxide production by neutrophils and other phagocytic cells. , 1990, Methods in enzymology.

[37]  M. Lyon,et al.  Localization of the human X-linked gene for chronic granulomatous disease to the mouse X chromosome: implications for X-chromosome evolution. , 1988, Cytogenetics and cell genetics.

[38]  S. Orkin,et al.  The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex , 1987, Nature.

[39]  P. Parker,et al.  The X-linked chronic granulomatous disease gene codes for the β-chain of cytochrome b −245 , 1987, Nature.

[40]  E. Robertson.  Teratocarcinomas and embryonic stem cells : a practical approach , 1987 .

[41]  F. Oski,et al.  Hematology of Infancy and Childhood , 1974 .